SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Current Liabilities
All obligations due within one year.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities of $6.67M in Q1 FY2026
Q1 FY2026 total current liabilities was $6.67M.
Context
- Total current liabilities amounted to 2.6% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 8.58M USD
- Year-over-year change
- —
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.58M | — |
Total Current Liabilities vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Total current liabilities amounts to 2.6% of total assets for SGP, versus a peer median of 13.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.79B USD | -6.5% | +3.7% | 8.9% | |
| Jun 2026 | $1.89B USD | +2.7% | +14.0% | 13.6% | |
| Jun 2026 | $102.33M USD | +29.3% | +11.9% | 11.1% | |
| Apr 2026 | $60.99M USD | -10.8% | +9.8% | 13.5% | |
| Mar 2026 | $47.68M USD | +25.7% | +17.4% | 6.5% | |
| Mar 2026 | CHF 43.73M CHF | +10.8% | +45.2% | 18.0% | |
| Mar 2026 | $37.46M USD | -10.1% | +2.3% | 13.0% | |
| Mar 2026 | $27.38M USD | +20.4% | +15.1% | 9.0% | |
| Mar 2026 | $18.16M USD | +49.8% | -14.8% | 16.6% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $6.67M USD | — | — | 2.6% |
| Peer median (excluding SGP) | — | +10.8% | +11.9% | 13.0% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.